Search   
MSDS  : Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha-isomer
CAS  : 319-84-6
SYNONYMS  : * Benzene hexachloride-alpha-isomer * alpha-Benzenehexachloride * alpha-BHC * Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha- * Cyclohexane, alpha-1,2,3,4,5,6-hexachloro- * ENT 9,232 * alpha-HCH * alpha-Hexachloran * alpha-Hexachlorane * Hexachlorcyclohexan * alpha-Hexachlorcyclohexane * alpha-Hexachlorocyclohexane * alpha-1,2,3,4,5,6-Hexachlorocyclohexane * 1-alpha,2-alpha,3-beta,4-alpha,5-beta,6-beta-Hexachlorocyclohexane * alpha-Lindane
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : GV3500000
CHEMICAL NAME : Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha-isomer
CAS REGISTRY NUMBER : 319-84-6
BEILSTEIN REFERENCE NO. : 3195880
REFERENCE : 4-05-00-00060 (Beilstein Handbook Reference)
LAST UPDATED : 199710
DATA ITEMS CITED : 38
MOLECULAR FORMULA : C6-H6-Cl6
MOLECULAR WEIGHT : 290.82
WISWESSER LINE NOTATION : L6TJ AG BG CG DG EG FG ALPHA
COMPOUND DESCRIPTOR : Agricultural Chemical
Tumorigen
Mutagen
Human
SYNONYMS/TRADE NAMES :
* Benzene hexachloride-alpha-isomer
* alpha-Benzenehexachloride
* alpha-BHC
* Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha-
* Cyclohexane, alpha-1,2,3,4,5,6-hexachloro-
* ENT 9,232
* alpha-HCH
* alpha-Hexachloran
* alpha-Hexachlorane
* Hexachlorcyclohexan
* alpha-Hexachlorcyclohexane
* alpha-Hexachlorocyclohexane
* alpha-1,2,3,4,5,6-Hexachlorocyclohexane
* 1-alpha,2-alpha,3-beta,4-alpha,5-beta,6-beta-Hexachlorocyclohexane
* alpha-Lindane

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human
DOSE/DURATION : 14 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85GYAV "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einer
Toxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R.,
Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 Volume(issue)/page/year:
-,54,1971

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 177 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see
PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2-
1939- Volume(issue)/page/year: 39,455,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 78 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OSDIAF Osaka Shiritsu Daigaku Igaku Zasshi. Journal of the Osaka City
Medical Center. (Osaka, Japan) V.4-23, 1955-74. For publisher
information, see OIGZDE. Volume(issue)/page/year: 15,553,1966

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 18 mg/kg/15D-C
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation,
etc.)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - catalases
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - other oxidoreductases
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 56,137,1991

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 36 mg/kg/30D-C
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation,
etc.)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - catalases
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - other oxidoreductases
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 56,137,1991

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 8736 mg/kg/26W-C
TOXIC EFFECTS :
Liver - changes in liver weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Related to Chronic Data - death
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 100,59,1950

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 20 gm/kg/48W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Liver - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
54,801,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5 gm/kg/24W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Liver - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
51,1637,1973

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 10 gm/kg/24W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Liver - tumors
REFERENCE :
NAIZAM Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara
Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken,
Japan) V.1- 1950- Volume(issue)/page/year: 25,635,1974

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11040 mg/kg/86W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
41,4140,1981

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 13020 mg/kg/92W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
41,4140,1981

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 12960 mg/kg/26W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Liver - tumors
REFERENCE :
CMSHAF Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1- 1972- Volume(issue)/page/year: 1,279,1972

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 8820 mg/kg/21W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC)
V.61-79, 1978-87. For publisher information, see JNCIEQ.
Volume(issue)/page/year: 71,1307,1983

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5040 mg/kg/24W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
SAIGBL Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo
Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160,
Japan) V.1- 1959- Volume(issue)/page/year: 17,54,1975

** MUTATION DATA **

TYPE OF TEST : Morphological transformation
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 2520 mg/kg/6W
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 9,387,1988

TYPE OF TEST : Unscheduled DNA synthesis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 100 umol/kg
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 8,1433,1987

TYPE OF TEST : Unscheduled DNA synthesis
TEST SYSTEM : Rodent - rat Liver
DOSE/DURATION : 10 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3010,1982

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 756 mg/kg/3W
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
54,1245,1975

*** REVIEWS ***

IARC Cancer Review:Animal Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 20,195,1979

*** OCCUPATIONAL EXPOSURE LIMITS ***

OEL-AUSTRALIA:TWA 0.5 mg/m3;Skin JAN 1993

OEL-BELGIUM:TWA 0.5 mg/m3;Skin JAN 1993

OEL-DENMARK:.TWA 5 mg/m3;Skin JAN 1993

OEL-DENMARK:TWA 0.5 mg/m3;Skin JAN 1993

OEL-DENMARK:TWA 0.5 mg/m3;Skin;Carcinogen JAN 1993

OEL-FINLAND:TWA 0.5 mg/m3;Skin;Carcinogen JAN 1993

OEL-FRANCE:TWA 0.5 mg/m3;Skin JAN 1993

OEL-GERMANY:TWA 0.5 mg/m3;Skin JAN 1993

OEL-HUNGARY:TWA 0.5 mg/m3;STEL 0.1 mg/m3;Skin JAN 1993

OEL-RUSSIA:STEL 0.05 mg/m3;Skin JAN 1993

OEL-SWITZERLAND:TWA 0.5 mg/m3;Skin JAN 1993

OEL-UNITED KINGDOM:TWA 0.5 mg/m3;STEL 1.5 mg/m3;Skin JAN 1993

*** STATUS IN U.S. ***

ATSDR TOXICOLOGY PROFILE
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB/90/171406/AS

EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-reversion

EPA TSCA Section 8(b) CHEMICAL INVENTORY

EPA TSCA Section 8(d) unpublished health/safety studies

On EPA IRIS database

EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JUNE 1998

NTP 7th Annual Report on Carcinogens, 1992 : anticipated to be carcinogen


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Cyclohexane, 1,2,3,4,5,6-hexachloro-, alpha-isomer 319-84-6
Cyclohexane, 1,2,3,4,5,6-hexachloro-, beta-isomer 319-85-7
Cyclohexane, 1,2,3,4,5,6-hexachloro-, delta-isomer 319-86-8
Cyclohexane, 1,2,3,4,5,6-hexachloro-, gamma-isomer 58-89-9
Cyclohexane, 1,2,3,4,5,6-hexachloro-, (mixed isomers) 58-89-9
Cyclohexane, hexadecafluorodimethyl- 26637-68-3
Cyclohexanecarbamic acid, 2-(diethylamino)ethylester, monohydrochloride 26637-68-3
Cyclohexane, 1,2,3,4,5,6-hexakis(2-cyanoethoxy)- 3055-84-3
Cyclohexanehydracrylic acid, alpha-phenyl-,2-(diethylamino)ethyl ester, hydrochloride 7477-25-0
Cyclohexanemethanol 100-49-2
Cyclohexanemethanol,alpha-(1-aminoethyl)-alpha-phenyl-, hydrochloride 100-49-2
Cyclohexanemethanol, alpha-(p-chlorophenyl)- 106165-42-8
Cyclohexanemethanol, alpha-(1,2-diaminoethyl)-,dihydrochloride, (+-)- 106165-42-8
Cyclohexanemethanol,alpha-(4-(diethylamino)-1-butynyl)-alpha-phenyl-,hydrochloride 4069-27-6
Cyclohexanemethanol,alpha-(1-(diethylamino)ethyl)-alpha-phenyl-,hydrochloride 4069-27-6
Cyclohexanemethanol,alpha-(2-(diethylamino)ethyl)-alpha-phenyl-,hydrochloride 13562-21-5
Cyclohexanemethanol,alpha-((diethylamino)phenylmethyl)-alpha-phenyl-,hydrochloride 13562-21-5
Cyclohexanecarbamic acid, 1,1-diphenyl-2-butynylester 20930-10-3
Cyclohexanemethanol,alpha-(1-(diethylamino)propyl)-alpha-phenyl-,hydrochloride 20930-10-3
Cyclohexanemethanol,alpha-(3-(diethylamino)-1-propynyl)-alpha-phenyl-,hydrochloride 20930-10-3
Cyclohexanemethanol,2-(dimethylamino)-alpha,alpha-diphenyl-,hydrochloride 20930-10-3
Cyclohexanemethanol,3-(dimethylamino)-alpha,alpha-diphenyl-,hydrochloride 20930-10-3
Cyclohexanemethanol,alpha-(2-(dimethylamino)ethyl)-alpha-phenyl- 24252-48-0
1,4-Cyclohexanemethanol, divinyl ester 17351-75-6
Cyclohexanemethanol, alpha-ethynyl-, acetate 16169-86-1
Cyclohexanemethanol, alpha-ethynyl-, carbamate 41416-61-9
Cyclohexanemethanol, alpha-ethynyl-4-phenyl-,carbamate, (E)- 41416-60-8
Cyclohexanemethanol, alpha-(1-hydrazinoethyl)-,hemisulfate (salt) 41416-60-8
Cyclohexanecarbamic acid, 1,1-diphenyl-2-propynylester 10087-89-5
Cyclohexanemethanol,4-hydroxy-alpha-(isopropylaminomethyl)- 63980-63-2
Cyclohexanemethanol,4-hydroxy-alpha-(methylaminomethyl)- 63918-84-3
Cyclohexanemethanol, alpha-methyl- 1193-81-3
Cyclohexanemethanol,alpha-(1-methylaminoethyl)-alpha-phenyl-,hydrochloride, DL- 1193-81-3
Cyclohexanemethanol, alpha-(methylaminomethyl)- 21581-48-6
Cyclohexanemethanol,alpha-(1-(1-methylhydrazino)ethyl)-, sulfate (2:1)(salt) 21581-48-6
Cyclohexanemethanol,alpha-(3-morpholino-1-propynyl)-alpha-phenyl-,hydrochloride 21581-48-6
Cyclohexanemethanol, 1-phenyl- 68692-77-3
Cyclohexanemethanol, alpha-phenyl-2-piperidino-,acetate, hydrochloride 101564-31-2
Cyclohexanemethanol, alpha-phenyl-1-piperidino-,hydrochloride 101564-32-3
Cyclohexanecarbamic acid, N-ethylthio-, S-ethyl ester 1134-23-2
Cyclohexanemethanol,alpha-phenyl-alpha-(3-piperidino-1-propynyl)-,hydrochloride 2269-28-5
Cyclohexanemethanol,alpha-phenyl-alpha-(3-(1-pyrrolidinyl)-1-propynyl)-,hydrochloride 2269-28-5
Cyclohexanemethanol, alpha-((2-pyridylamino)methyl)-,hydrochloride 1020-19-5
Cyclohexane, methyl- 108-87-2
Cyclohexanemethylamine 3218-02-8
Cyclohexanemethylamine,4-(4-aminophenyl)-alpha-methyl-, oxalate, hydrate(2:2:1), (E)- 113524-37-1
Cyclohexanemethylamine, alpha-benzyl-N,N-dimethyl-,hydrochloride 113524-37-1
Cyclohexanemethylamine,4-(4-bromophenyl)-alpha-methyl-, hydrochloride, (E)- 113524-38-2
Cyclohexanemethylamine,N-(2-chloroethyl)-N-ethyl-1-phenyl-, hydrochloride 101564-53-8
Cyclohexanemethylamine, 2-chloro-2-(m-methoxyphenyl)- 73806-38-9

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net